Literature DB >> 10215485

A 1H MRS study of probable Alzheimer's disease and normal aging: implications for longitudinal monitoring of dementia progression.

S E Rose1, G I de Zubicaray, D Wang, G J Galloway, J B Chalk, S C Eagle, J Semple, D M Doddrell.   

Abstract

In order to evaluate the capability of 1H MRS to monitor longitudinal changes in subjects with probable Alzheimer's disease (AD), the temporal stability of the metabolite measures N-acetylaspartate and N-acetylaspartylglutamate (NA), total Creatine (Cr), myo-Inositol (mI), total Choline (Chol), NA/Cr, mI/Cr, Chol/Cr and NA/mI were investigated in a cohort of normal older adults. Only the metabolite measures NA, mI, Cr, NA/Cr, mI/Cr, and NA/mI were found to be stable after a mean interval of 260 days. Relative and absolute metabolite measures from a cohort of patients with probable AD were subsequently compared with data from a sample of normal older adult control subjects, and correlated with mental status and the degree of atrophy in the localized voxel. Concentrations of NA, NA/Cr, and NA/mI were significantly reduced in the AD group with concomitant significant increases in mI and mI/Cr. There were no differences between the two groups in measures of Cr, Chol, or Chol/Cr. Significant correlations between mental status as measured by the Mini-Mental State Examination and NA/mI, mI/Cr and NA were found. These metabolite measures were also significantly correlated with the extent of atrophy (as measured by CSF and GM composition) in the spectroscopy voxel.

Entities:  

Mesh:

Year:  1999        PMID: 10215485     DOI: 10.1016/s0730-725x(98)00168-4

Source DB:  PubMed          Journal:  Magn Reson Imaging        ISSN: 0730-725X            Impact factor:   2.546


  37 in total

1.  Evidence for altered hippocampal volume and brain metabolites in workers occupationally exposed to lead: a study by magnetic resonance imaging and (1)H magnetic resonance spectroscopy.

Authors:  Yue-Ming Jiang; Li-Ling Long; Xia-Yan Zhu; Hong Zheng; Xue Fu; Shi-Yan Ou; Dong-Lu Wei; Hai-Lin Zhou; Wei Zheng
Journal:  Toxicol Lett       Date:  2008-07-23       Impact factor: 4.372

2.  Automatic repositioning of MRSI voxels in longitudinal studies: impact on reproducibility of metabolite concentration measurements.

Authors:  Eva-Maria Ratai; Ileana Hancu; Daniel J Blezek; Katherine W Turk; Elkan Halpern; R Gilberto González
Journal:  J Magn Reson Imaging       Date:  2008-05       Impact factor: 4.813

3.  Magnetization transfer imaging and proton MR spectroscopy in the evaluation of axonal injury: correlation with clinical outcome after traumatic brain injury.

Authors:  G Sinson; L J Bagley; K M Cecil; M Torchia; J C McGowan; R E Lenkinski; T K McIntosh; R I Grossman
Journal:  AJNR Am J Neuroradiol       Date:  2001-01       Impact factor: 3.825

Review 4.  Various MRS application tools for Alzheimer disease and mild cognitive impairment.

Authors:  F Gao; P B Barker
Journal:  AJNR Am J Neuroradiol       Date:  2014-04-17       Impact factor: 3.825

5.  Selective reduction of N-acetylaspartate in medial temporal and parietal lobes in AD.

Authors:  N Schuff; A A Capizzano; A T Du; D L Amend; J O'Neill; D Norman; J Kramer; W Jagust; B Miller; O M Wolkowitz; K Yaffe; M W Weiner
Journal:  Neurology       Date:  2002-03-26       Impact factor: 9.910

6.  ¹H- and ¹³C-NMR spectroscopy of Thy-1-APPSL mice brain extracts indicates metabolic changes in Alzheimer's disease.

Authors:  A Doert; U Pilatus; F Zanella; W E Müller; G P Eckert
Journal:  J Neural Transm (Vienna)       Date:  2015-03-06       Impact factor: 3.575

7.  Effects of Alzheimer disease on fronto-parietal brain N-acetyl aspartate and myo-inositol using magnetic resonance spectroscopic imaging.

Authors:  Xiaoping Zhu; Norbert Schuff; John Kornak; Brian Soher; Kristine Yaffe; Joel H Kramer; Frank Ezekiel; Bruce L Miller; William J Jagust; Michael W Weiner
Journal:  Alzheimer Dis Assoc Disord       Date:  2006 Apr-Jun       Impact factor: 2.703

Review 8.  Magnetic resonance imaging and magnetic resonance spectroscopy in dementias.

Authors:  Y Y Hsu; A T Du; N Schuff; M W Weiner
Journal:  J Geriatr Psychiatry Neurol       Date:  2001       Impact factor: 2.680

Review 9.  Proton MRS in mild cognitive impairment.

Authors:  Kejal Kantarci
Journal:  J Magn Reson Imaging       Date:  2013-04       Impact factor: 4.813

10.  The relationship between cognitive impairment and in vivo metabolite ratios in patients with clinical Alzheimer's disease and vascular dementia: a proton magnetic resonance spectroscopy study.

Authors:  A D Waldman; G S Rai
Journal:  Neuroradiology       Date:  2003-07-22       Impact factor: 2.804

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.